Abraham H. Dachman to Disease-Free Survival
This is a "connection" page, showing publications Abraham H. Dachman has written about Disease-Free Survival.
Connection Strength
0.014
-
Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer. J Clin Oncol. 2005 Nov 01; 23(31):8033-40.
Score: 0.014
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.